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1. Introduction  
In this review, we aim to highlight the importance of neuropharmacological data, originated 
in non-human primate studies, towards our understanding of the mechanisms of cocaine 
addiction. Most studies in this field are undertaken with rodents as animal models, having 
provided over the years important knowledge on the behavioral, neurological and 
pharmacological mechanisms of drug addiction. There are, nonetheless, significant 
hormonal, neurochemical and neuroanatomical discrepancies between rodents and 
primates, particularly in reference to humans. Although the phylogenetic distance between 
humans-rodents, as opposed to humans-non-human primates may seem obvious, the 
impact this has on research findings is not always very evident. The gap in brain chemistry, 
neuronal organization and development, as well as behavioral diversity has serious 
implications in rodent models and limits somewhat their significance and generalization 
potential when trying to understand cocaine addiction – a phenomenon typical in humans. 
Due to ethical and important methodological restrictions on human testing, non-human 
primate (NHP) models are not only insightful, but also crucial to further the current 
scientific knowledge on this topic.   
2. Addiction and cocaine 
Cocaine is one of the most prevalent drugs of abuse. Data from the World Health 
Organization (WHO) estimated that, until 2008, approximately 19 million people worldwide 
had made use of cocaine (WHO, 2010). While the illicit retail market of cocaine is deemed to 
be worth around US$ 88 billions per year (WHO, 2009), its economic burden is difficult to 
measure. In terms of health treatment costs, there were 31,800 drug-related deaths in the 
United States alone in 2007 – a rate twice as high as that for murder in that year – with 
cocaine being related to about 40% of this toll. From 2002 to 2007, the WHO estimates that 
these premature deaths cost around 33 billion dollars. The American Drug Control 
program’s budget for all drug-related control efforts in 2011 corresponds to US$15 billion, 
including treatment, prevention and illicit trade combat (National Drug Control Budget, 
2011). Most of this will be spent on cocaine control, as the USA is the major destination of 
cocaine exports (WHO). On the other hand, the global cost of cocaine is less clear, 
considering that data from several countries are less reliable or regular.  
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Cocaine addiction is a psychological substance dependence where addicts have great 
difficulty in abstaining from drug-seeking, even at the cost of evident negative consequences 
(Vanderschuren & Everitt, 2004). It is a relapsing disorder with pervading effects on the 
human brain (O’Brien, 1997). Repeated use of cocaine leads to sensitization, i.e. enhanced 
response to the stimulus. In this case, repeated cocaine intake induces increased motor 
response and motivation (Robinson & Berridge, 2008). Sensitization is a long-lasting 
behavioral phenomenon with several implications to addiction (Paulson et al., 1991). The 
enduring sensitization induced by cocaine is linked to the relapsing properties of this 
disorder. Relapse or reinstatement is the return of drug-seeking or drug-taking behavior 
after a drug-free interval. In animal models, reinstatement has been shown to take place 
with priming injections of the drug (de Wit & Stewart, 1981), other compounds (Crombag et 
al., 2002), re-exposure to environmental cues associated with drug-taking (Meil & See, 1996) 
or even by stressful events (Anker & Carroll, 2010). In fact, cocaine relapse is one of the most 
difficult obstacles for the rehabilitation of addicts (O’Brien, 1997), possibly being related to 
cocaine sensitization of motivation or stimulus salience and not sensitization of locomotor 
activity (Robinson & Berridge, 2008). 
Although progress in understanding the function of the brain and addiction has been made, 
there is still no pharmacological treatment that effectively blocks cocaine dependence, even 
after 30 years or so of research. Therefore, it is evident that cocaine addiction is a lingering 
and crippling health issue that warrants continued attention from the scientific community.  
3. The case for non-human primates as models  
As in the case of most biomedical fields, rodent models stand as the primary source of data 
in the study of addiction. Their small size and short reproductive cycle makes them easy to 
maintain, handle and reproduce, as well as relatively inexpensive in up keeping in 
laboratories around the world. Nevertheless, rats and mice did not reach this ubiquity in 
biomedical research on these merits alone. Rodent models have proved reliable in a wide 
range of topics, from drug screening to cognitive tests (eg. Fouquet et al., 2010; Heinrichs, 
2010; Schmidt et al., 2011). Naturally, the versatility of these subjects has reflected on the 
enormous amount of scientific literature and experimental apparatus that have been 
generated over the course of the last five decades. The extensive amount of rodent research 
also spurs a faster refinement of the techniques, which in turn, makes rodents an even more 
practical and useful model. In terms of cocaine addiction, rats have been employed in 
several paradigms (self-administration, conditioned place-preference, open field; Mello & 
Negus, 1996; Ator & Griffiths, 2003) and also make up the majority of cocaine-related 
studies. Unfortunately, there is a significant genetic gap between humans and rodents: the 
actual figure being 66-82% homology (Nilsson et al., 2001). This difference has several 
implications in the understanding of cocaine abuse in humans. 
NHP have been employed in addiction paradigms for approximately 40 years (Thompson 
and Schuster, 1964; Griffiths et al., 1980; Mello and Negus, 1996). Although the primate 
database on addiction is less abundant than that of rodents’, there is considerable 
information available for comparison and interpretation. The genetic homology between 
NHP and human falls within 95%, depending on the species considered (Hacia et al., 1998). 
A greater phylogenetic proximity reflects on a more similar anatomy, physiology and 
behavior. In the sections below, we will examine the most important discrepancies between 
rodents and NHP and the contributions of primate research to the understanding of cocaine 
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addiction. The importance of NHP however does not lie solely on their genetic distance to 
rodents. There is rather a powerful tool in primate research that allows for a greater and 
more refined analysis of the intricacies of cocaine effects: primate behavior. 
In this sense, one of the most widespread and reliable tests for cocaine addiction is the self-
administration paradigm (Griffiths et al., 1980; Ator & Griffiths, 2003). In this model, the 
animal subject is trained to press a lever or push a button to receive a rewarding stimulus 
(e.g. electrical stimulation to “rewarding centers” in the brain or a direct infusion of an 
addictive substance). There are several schemes under which this paradigm may work for 
both rodents and NHP. Nevertheless, there is a limit to how many response parameters one 
may expect to gather from rats and mice. The great advantage of primate research is the 
plethora of behaviors that may be drawn upon, ranging from simple self-directed behaviors, 
to very complex social behaviors. All apes and monkey species present high cognitive 
indices and good manipulatory skills (Pouydebat et al., 2009, 2011). They may form large 
social structures, including even non-kin members. As a result, there are quite complex 
social situations that entail a variety of social cues and behaviors. For instance, they display 
(and react appropriately to) facial expressions signaling emotional states or intentions 
beyond only aggressiveness, as in the case of most non-primates species (Schimidt & Cohn, 
2001). They may even engage in very cognitively demanding behaviors such as deception 
(Reader et al., 2011). Thus, the use of a species-appropriated ethogram may add a wealth of 
new data even to simple reaction time experiments. Models may be improved to resemble 
very closely human social conditions or complex cognitive tasks that models human drug-
seeking behavior. As pointed out by Nader and coworkers (2008), “…all animal models are, 
as a minimum, predictive of some clinical outcome… When social behaviors of NHP and 
cocaine self-administration (for example) are included, these models are homologous 
models of human drug abuse.” Indeed, some paradigms have included social variables in 
the study of cocaine abuse (Czoty et al., 2005; Morgan et al. 2002).  
Furthermore, physical reactions to compounds or the abstinence thereof mirrors very closely 
those of humans. For example, NHP demonstrate all key signs of opioid withdrawal seen in 
humans, including retching, hiccups, pallor and abdominal cramps (see Weerts et al., 2007). 
Rodents, on the other hand, lack those and several other symptoms. Likewise, more subtle 
and yet relevant drug effects, such as hallucinatory behavior, are only clearly discernible in 
NHP (Castner & Goldman-Rakic, 2003; Ellison et al., 1981).  
In the case of addiction, NHP longevity is also another advantage. Most ape and monkey 
species tend to live quite long; a few may even live beyond the age of 40 (Judge & Carey, 
2000). This has important implications for the study of long-term effects of drug abuse. It 
means, among other aspects, that long-term effects of cocaine consumption may be more 
easily modeled for a specific developmental stage, such as adolescence. It also allows studies 
of a drug’s cumulative effects or cross-drug comparisons in the same subject (Ator & 
Griffiths, 2003). Together with their greater physiological similarities and behavioral 
diversity, longevity makes NHP models key for addiction research. 
At this point, it is important to add a caveat to our argument. Although NHP might prove 
crucial to research in most biomedical fields, for several reasons it may not always be the 
ideal model for many laboratories worldwide. First, primates require appropriate facilities 
that cater to their size, locomotion, habits and social needs. This makes primate research 
considerably more expensive than working with rats or mice. Longer reproductive cycles 
and development stages also reduce the pace of any experimental output. Even small 
species offers difficulty in handling and training. Another restriction refers to the lack of 
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background research on the behavior and/or physiology for several primate species. 
Behavioral ethograms, for instance, are not always readily available in the literature. Lastly, 
ethical considerations regarding the availability of specimens and the threat of extinction for 
some species may also limit the use of primates. Therefore, we are not advocating the use of 
primates as the primary source of scientific data. Biomedical research will still rely heavily 
on rodent studies, and rightly so. One of the aims of the present review is to advise that 
caution should be taken before generalizing rodent findings to human and to show how 
NHP research may help bridge the gap between them. 
3.1 Dopamine 
The primary focus of cocaine research, as well as most drug of abuse, is the brain’s 
dopaminergic system. Dopamine (DA) is a neurotransmitter produced in the substantia 
nigra, ventral tegmental area (VTA) and hypothalamus. The projection of VTA 
dopaminergic neurons reaches two main targets in the brain: the prefrontal cortex 
(mesocortical pathway) and the ventral striatum (mesolimbic pathway). Both comprise what 
is called the reward system, with the mesolimbic pathway playing a major role (see 
Berridge, 2007 and Wise, 1996 for review). Not surprisingly, the rewarding and 
psychostimulant effects of cocaine are mediated by its ability to enhance dopaminergic 
activity within the meso-cortico-limbic circuit (Roberts et al., 1977). Briefly, cocaine binds to 
and blocks the pre-synaptic transporter responsible for DA re-uptake (Heikkila et al., 1975; 
Ritz et al., 1987,). This dopamine transporter is referred to as DAT. As DA reuptake is 
inhibited, the synaptic cleft is overflown with DA that will bind to post-synaptic receptors, 
inducing a prolonged or enhance signaling effect.   
The DA receptors are classically divided into 5 subtypes, classified as: D1, D2, D3, D4 and D5. 
These subtypes have been further divided and organized into two main groups, the ‘D1-like’ 
receptors: D1/D1a, D5/D1b, D1c and D1d; and the ‘D2-like’ receptors: D2long and short, D3, D4 or 
D2al and s, D2b and D2c (Sibley and Monsma, 1992). D1-like and D2-like are traditionally 
involved in the rewarding properties of stimuli such as cocaine (Hummel & Unterwald, 
2002; Di Chiara et al., 2004). In this regard, several studies have reported critical differences 
between rodents and primates. NHP post-synaptic D1-like receptors show higher levels and 
their laminar distribution is more complex than in rodents, but similar to humans (Smiley et 
al., 1994). Regarding the densities of D2-like receptors, Lidow and coworkers (1989) showed 
a distinct pattern of distribution in the primate cortex: a rostro-caudal gradient, with the 
prefrontal cortex showing the highest concentration and the occipital cortex the lowest. Rats, 
on the other hand, were found to have a more diffuse distribution of these receptors. More 
specifically, the ratio between D1-like and D2-like receptors in the NHP striatum is almost 
1:1 (Madras et al, 1988; Weed et al, 1998), whereas D1-like receptors are three times more 
prevalent than D2-like (Hyttel and Arnt, 1987; Weed et al, 1998). The density ratio in humans 
seems to follow the same pattern as that observed in NHP (Hall et al, 1994; Piggott et al, 
1999). There is also greater similarity between humans and NHP in the distribution of D1-
like (Hersi et al., 1996) and D2-like receptors in the hippocampal formation (Kohler et al., 
1991). These are also reflected in low ligand efficacy of D1-like receptor agonists in the 
primate brain (Izenwasser & Katz, 1993; Pifl et al., 1991; Vermeulen et al., 1994). 
The distribution and the organization of DA receptors are not the only discrepancies 
concerning the DA system. An early review from Berger and coworkers (1991) noted 
important differences in the organization of primate and rodent DA cells. They indicated 
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larger and differentially organized terminal fields in the DA mesocortical pathway in 
primates. DA cells arriving in the rat striatum are clearly organized into two tiers, ventral 
and dorsal, whereas no such distinction is found in monkeys (Joel & Weiner, 2000). 
Cytoarchitecture of midbrain DA cells in monkeys and humans is noticeably different with 
large and dense dendritic plexuses (Gonzalez-Hernandez et al., 2004). The primate cortex 
shows a higher density of DA innervation, as compared to rodents (Goldman-Rakic et al., 
1992; Goldman-Rakic et al., 1989). Goldman-Rakic and coworkers (1992) emphasized that 
the cortical DA system in rhesus monkeys is near identical to that of humans. Both species 
show a bi-laminar innervation of the prefrontal cortex with projections reaching upper and 
deep cortical areas. These discrepancies bear important consequences for cocaine addiction 
studies. For instance, the development of compounds that may block cocaine addictive 
effects will probably depend on receptor specificity.  
It is noteworthy that greater focus is generally given to rodent pathways that show high 
homology with humans. Nevertheless, a few promising options may remain unexplored if 
NHP are not employed. For instance, the rat thalamus is very poorly innervated by DA 
neurons (Groenewegen, 1988). Only recently has some attention been given to the multiple 
DA projections to the thalamus in the monkey and human brain (Sanchez-Gonzalez et al., 
2005). Likewise, drug screening may be severely restricted by results in rodents. As pointed 
out by Weerts and coworkers (2007), “unacceptable performance in the rat can result in 
termination of further examination of a compound or an entire chemical series”.  
All the physiological and anatomical dissimilarities between primates and rodents seem to 
bear on the dynamics of DA circuits and its associated metabolism. Cocaine infusion in NHP 
was shown to reduce glucose metabolism in several brain regions, including the prefrontal 
cortex and the ventral striatum, in a manner similar to that reported in human studies 
(London et al., 1990; Pearlson et al., 1993; Lyons et al. 1996). The effect seems to reduce 
metabolism also in cortical areas projecting to the ventral striatum (Lyons et al. 1996; 
Porrino et al., 2002). This is in clear opposition to rodent findings, where metabolic activity 
is increased, not decreased, being also restricted to dopaminergic circuits (Hammer & 
Cooke, 1994; Porrino et al., 1988).  
The pharmacokinetics of the DA system also shows important differences in behavioural 
profiles. In NHP, rate-increasing effects of cocaine seem not to be important for the 
reinstatement of behavior after extinction (Banks et al. 2007). Odum and Shahan (2004) had 
found earlier that also the psychostimulant amphetamine significantly increased 
extinguished responding. Lile and co-workers also reported that cocaine and DA agonists 
induce different behavioural effects in monkeys and challenged the accepted influence of 
neurotransmitters transporters in reinforcement, as previously established in rats (Lile et al. 
2003; Roberts et al. 1999). This became clearer when Letchworth and coworkers (2001) found 
long-term cocaine-induced increases in DAT densities in monkey striatum, which is not seen 
in rodents but is quite similar to human studies. 
Regarding drug abuse in general, the DA system has been the most extensively investigated 
pathway. Despite this, its causal role in the reward system is still under debate. In short, 
three competing hypotheses have been put forward: (1) DA mediates the hedonic aspects of 
reward (i.e. ‘liking’; Wise, 1980); (2) DA mediates the prediction of rewards concordant with 
associative learning (Schultz, 2004); and (3) DA mediate the motivational aspect of drug-
seeking behavior by attributing incentive salience to reward-related stimuli (i.e. ‘wanting’; 
Berridge & Robinson, 1998). In a detailed review of mostly rodent literature, Berridge (2007) 
examined the findings from the last 30 years and concluded that there is more support for 
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the incentive salience hypothesis. However, there is also support from a few 
electrophysiological studies in monkeys showing that DA neurons cease to fire after reward-
related cues have been learned (Schultz, 2006). 
Nonetheless, primate studies have yielded a few other contributions. The study of cocaine-
induced response sensitization also showed striking differences between primate and 
rodents. Rats generally display a dose-dependent sensitization of DA reinforcing responses 
(Liu et al., 2005). Chronic exposure to cocaine or amphetamine, on the other hand, has failed 
to produce sensitization in NHP (Castner et al., 2000; Bradberry & Rubino, 2006; Castner & 
Williams, 2007), which is in agreement with human imaging studies (Volkow et al. 1997; 
Martinez et al. 2003). Similarly, cocaine-associated cues have been shown to induce DA 
release in the rat striatum (Ito et al., 2002; Weiss et al. 2000). Similar studies with monkeys 
were unable to produce significant increases in extracellular DA in either the striatum or 
cortex (Bradberry, 2000; Kimmel et al. 2005). Human findings, via imaging studies, seem to 
agree with NHP results, although DA release was not measured directly (see Bradberry, 
2007 for review). It is beyond the scope of the present review to try to settle the issue of DA 
causal role in drug abuse. Instead, the data shown here underscores critical NHP findings 
that put rodent studies in perspective. 
Overall, the data reviewed above indicates that rodent DA system differs significantly from 
humans’. This is important to keep in mind when analyzing results from rats and mice 
studies. Although rodent studies provide the initial step of investigation, data obtained from 
such models are not easily generalized to humans. In some cases they may even bias 
investigation towards rodent-related issues. As we shall see further, there are also important 
differences concerning serotonin (5-HT), neuropetides and hormones. However, these 
systems have been studied less extensively in the framework of cocaine abuse, but their 
importance is gradually becoming clearer.  
3.2 Serotonin 
Serotonin or (5-hydroxytryptamine [5-HT]) is an important neurotransmitter in the brain. It 
is mostly synthesized in the raphe nuclei in the midbrain and from there 5-HT neurons 
project to several regions in the brain (Kazakov et al., 1993). There are at least 14 types of 5-
HT receptors grouped into seven families (see Roth, 2006), with 5-HT1 and 5-HT2 being the 
most relevant and widespread in the human brain (Glennon et al., 2000). The release of 5-HT 
is modulated by the inhibition of two types of 5-HT auto-receptors: cell body and fiber 
terminal (Price et al., 1996).  
As in the case of DA receptors, discrepancies between rodent and primate 5-HT auto-
receptor distribution have been reported. 5-HT1A distribution in rats and humans seem to be 
highly congruent (Hartig et al., 1992). Autoradiographic assays, however, have shown an 
abundance of 5-HT1A mRNA expression in the superficial layers of monkeys’ prefrontal 
cortex (de Almeida & Mengod, 2008; Marazziti et al. 1994; Mengod et al. 1996). This suggests 
that raphe nuclei efference may modulate high-level cortico-cortical communication in 
primates. In rodents, 5-HT1A mRNA seems to be restricted to the deeper layers of the 
prefrontal cortex (Pompeiano et al., 1992; Santana et al., 2004) and therefore would not exert 
the same influence on cortical activity.  
Although data on 5-HT1A distribution throughout the brain is still lacking for NHP, there is 
little reason to suppose it differs much from humans and rodents. The same does not hold 
true, for example, in the case of 5-HT2A receptors. High densities of this receptor were found 
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in the rat caudate, putamen and accumbens nuclei, as well as 5-HT2A mRNA in the caudate, 
putamen and substantia nigra (Lopez-Gimenez et al., 2001). This may reflect the fact that 5-
HT neurons in the rat striatum are not as evenly distributed as in NHP (Ikemoto et al., 1996; 
Van Bockstaele et al. 1993). A similar pattern emerges from immunohistochemical assays on 
5-HT transporting proteins (SERT), where rats show a more heterogeneous distribution than 
primates (Owashi et al., 2004). In spite of some efforts, there is as serious lack of data 
regarding the distribution specific 5-HT receptors in NHP brains. At this point, the 
involvement of 5-HT in cocaine behavioral effects still seems quite complicated (eg. Dic 
Dhonnchadha & Cunningham, 2008) and unfolding the intricacies of serotonergic system in 
the primate brain may prove crucial.  
Nevertheless, the basic interaction between cocaine and 5-HT seems to be the same as DA. 
Besides its effects on DAT, cocaine is also a potent inhibitor of 5-HT reuptake: it binds 
strongly to SERT, thereby preventing their reuptake by pre-synaptic cells (Heikkila et al., 
1975; Ritz et al., 1987; Ritz et al., 1990). There are, once again, discrepancies in how cocaine 
affects rodent and primate serotonergic transmission. Work from Miller and coworkers 
(2001) showed that although both rodents and NHP share a high similarity in DAT sequence 
homology with humans (≅ 98.9%). In the case of SERT, NHP to human homology is slightly 
lower (98.3%), and even lower in for rodents (95%). Not surprisingly, SERT inhibition has an 
inverted effect on rats and primates, where it strengthens the discriminative stimulus of 
cocaine and has no impact on self-administration on the former (Tella, 1995), while it 
reduces the discriminative stimulus and self-administration in the latter (Howell & Byrd, 
1995; Spealman, 1995).  
Although the effects of cocaine on 5-HT inhibition were already well established by the 
early 1990s (Cunningham & Lakoski, 1990; Cunningham et al., 1992), it was only more 
recently that 5-HT neurotransmission was implicated in the cocaine-increased locomotor 
activity in rats (Hergers & Taylor, 1998). These findings were further explored by Carey and 
coworkers (2000, 2001 and 2005) showing that cocaine-induced locomotor activity in rats 
was mediated more specifically by 5-HT1A receptors. Although self-administration of 
cocaine seems unaffected by 5-HT1A manipulations in rats (Parsons, Weiss, & Koob, 1998), 
low doses of highly selective 5-HT1A antagonist WAY100635 were shown to block cocaine-
induced hyperlocomotion, whereas pre-treatment with 8-OHDPAT (5-HT1A partial agonist) 
enhanced it. These findings were corroborated in NHP, where WAY100635 also blocked 
increases in locomotion induced by diethylpropion, an amphetamine-like drug (Mello Jr. et 
al., 2005). Pharmacological antagonism of this particular subtype of receptor showed 
conflicting results in rodent stress and anxiety tests (Fletcher et al., 1996; Griebel et al., 2000; 
Bell et al., 1999; Groenink et al., 1996). In monkeys, WAY100635 reduced anxiety behaviors 
in a confrontation model (Barros et al., 2003). These results are important if one considers 
the fact that stress and anxiety may trigger relapse in cocaine addicts (Steketee & Kalivas, 
2011). Also 5-HT1A agonism has been shown to enhance cocaine’s reinforcing effects in NHP 
(Czoty et al., 2002). 
The role of 5-HT on cocaine relapse seems to be related not only to its involvement in 
anxiety and stress processes. 5-HT may influence cocaine relapse due to its role in memory 
retrieval (Molodtsova, 2008). In rodents, the non-selective 5-HT1B/1A agonist RU24969 was 
shown to reduce the retrieval of cocaine induced cues (Acosta et al., 2005). This effect was 
reversed by 5-HT1B antagonism which indicates prevalence of 5-HT1B receptor in this case. 
Antagonism of 5-HT1B receptors receptors seems to have no effect of their own on cocaine-
related memories or behavior reinstatement. There are no reports on the effects of 5-HT1A 
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agonists on retrieval of cocaine operant behavior per se, but one study found a reinstatement 
of cocaine-induced locomotor behavior (Carey et al., 2009). Retrieval of cocaine-associated 
memories in rats was also shown to be impaired by 5-HT2A antagonism (Burmeister et al., 
2004; Fillip, 2005) and 5-HT2C agonism (Burbassi & Cervo, 2008; Fletcher et al., 2008; 
Neisewander & Acosta, 2007).  
Although the understanding of 5-HT receptor’s modulation of cocaine-related memory is still 
inceptive, Nic Dhonnchadha & Cunningham (2008) argued that future research should focus 
on 5-HT1B, 5-HT2A and 5-HT2C. To our knowledge, the effects of 5-HT1A/1B and 5-HT2A/2C 
pharmacological manipulation on cocaine-associated memories have yet to be tested. 
Nevertheless, disparities of primate and rodent serotonergic system warrant a broader stance 
for future research. Although 5-HT1B and 5-HT2A/2C modulation enhance self-administration in 
both species (Bubar & Cunningham, 2006; Czoty et al., 2005; Fletcher et al., 2002; Howell & 
Byrd, 1995; Parsons, Weiss, & Koob, 1998), 5-HT1A agonism has shown to enhance the 
reinforcing properties of cocaine only in primates (Gold & Balster, 1992; Nader and Barrett, 
1990). Therefore, differences in 5-HT reinforcing effects between rodents and NHP may very 
well transpose to cocaine-associated memories or even provide a entirely distinct pattern. 
3.3 Peptides 
Compared to DA and 5-HT, the role of neuropeptides in the effects of cocaine remains 
largely unknown. Nonetheless the past 20 years have witnessed important advances, 
especially in two fronts: tachykinin receptors and cocaine-and-amphetamine regulated 
transcript (CART). As shown below, the differences in primate and rodent brain regarding 
these two neuropeptides should exact caution from researchers. 
Tachykinins comprise a group of neuropeptides that share a common C-terminal sequence 
(Phe-X-Gly-Leu-Met-NH2), with five known mammalian tachykinins: substance P - SP, 
neurokinin A (NKA), neurokinin B (NKB), neuropeptide K and neuropeptide g. They have 
been shown to bind to three specific tachykinin receptors: NK1, NK2 and NK3. NK1-Rs and 
NK3-Rs are widely distributed in the brain, while the NK2-Rs are found only in restricted 
areas. Although SP, NKA and NKB have a high binding affinity to the NK1-R, NK2-R and 
NK3-R, respectively, all tachykinins bind to all three receptor types (Severini et al., 2002).  
In rats, cocaine administration induced the expression of tachykinin-related mRNA in the 
striatum (Adams et al., 2001; Arroyo et al., 2000; Johansson et al., 1994; Hurd et al., 1992; 
Mathieu-Kia & Besson, 1998). It also increased SP immunoreactivity in the striatum, 
substantia nigra and frontal cortex (Alburges et al., 2000). Nevertheless, results from NK1 
manipulations on cocaine effects in rodents have been controversial so far. NK1 antagonism 
was shown to block cocaine-induced hyperlocomotion (Kraft et al., 2001), reverse 
sensitization (Davidson et al., 2004) and reduce cocaine-induced DA increases in the 
striatum (Loonam et al., 2003). NK1 agonism reinstated cocaine operant behaviors, yet SP – 
which binds preferentially to NK1 – failed to replace cocaine (Ukai et al., 1995). NK1 
knockout mice showed no difference in cocaine self-administration and sensitization, as 
compared to controls (Ripley et al., 2002).  
In the case NK3 receptors, there are a few reports implicating its activity in alcohol addiction 
in rats (Ciccocioppo et al., 1998; Massi et al., 2000). Also, NK3 activation in the VTA has been 
shown to reinstate cocaine-seeking behavior (Placenza et al., 2004) and its antagonism seems 
to block cocaine sensitization (Nwaneshiudu & Unterwald, 2010). In a joint effort from 
Huston and Tomaz’s groups, a series of comparative studies regarding the involvement of 
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NK3 receptors in the effects of cocaine in rats and marmoset monkeys has been carried out. 
In rats, NK3 antagonist SR142801 reduced behavioral effects of cocaine, but increased DA 
action in the ventral nucleus accumbens and showed no significant effect on conditioned 
place preference (Jocham et al., 2006). It also had no individual effect on DA content in the 
striatum. In monkeys, the same antagonist blocked cocaine-induced effects in a range of 
behaviors, including locomotion and vigilance (De Souza Silva et al., 2006b). It also had no 
effect per se. In contrast, NK3 agonist senktide showed discrepancies between the two 
species. In rats, senktide increased both cocaine-induced hyperlocomotion and the DA 
response in the nucleus accumbens (Jocham et al., 2007). Senktide alone induced a brief 
increase in activity but no neurochemical changes. On the other hand, this same compound 
blocked cocaine-induced hyperlocomotion in monkeys, although it enhanced cocaine’s 
effects on exploratory activity and some vigilance behaviors dose-dependently (Fig. 1; De 
Souza Silva et al., 2006a). Furthermore, unlike rats, senktide did not induce significant 
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behavioral changes on its own (Fig 1A). These conflicting findings may be due to relevant 
differences in NK3 receptor distribution between rodents and NHP (Langlois et al., 2001). 
Despite that, NK3 receptor seems to be an interesting target for investigation and future 
therapeutic intervention of cocaine addiction.  
CART is an mRNA identified in 1995, whose transcription seems to be modulated by 
psychostimulants (Douglas et al., 1995). It encodes two proteins in the rat (short and long 
CART), but only one in humans (short). In CART knockout mice, cocaine and amphetamine 
locomotor and reinforcing effects were reduced (Couceyro et al., 2005). The literature on 
CART research in primates, however, is scarce. There is one recent comparative report on 
the cocaine-induced expression of CART in the rat and monkey brain (Fagergren & Hurd, 
2007). They report a higher expression of CART mRNA in the primate frontal and temporal 
cortices, positive labeling confined to the shell-like region of the striatum, different 
distribution in the hippocampal formation and more markedly differences in the thalamus. 
These aspects are different from those in rats, yet seem to be in agreement with human 
studies. Limbic distribution of CART mRNA was overall very similar to that of rodents’. 
However, the authors point that they were unable to investigate the nucleus accumbens 
where cocaine had been shown to induce increases in CART mRNA in humans (Albertson 
et al., 2004).  
In summary, neuropeptidic involvement in cocaine-induced effects is beginning to provide 
important insights. The scarcity of primate studies on the subject is unsettling, considering 
that the discrepancies with rodents’ anatomy and physiology are not trivial. There is, for 
instance, an absence of co-localization of several neuropeptides with DA in primates 
(Gaspar et al., 1990; Oeth & Lewis, 1992). Although the discovery of CART is fairly recent, 
compounds acting on NK1- and NK3-receptors have been under investigation for quite 
some time. Regardless, the understanding of tachykinins’ influence on cocaine addiction 
seems to be progressing in a very slow pace. 
3.4 Hypothalamic-pituitary-adrenal (HPA) axis 
Another key aspect of psychostimulant effects concerns the neuroendocrine system. 
Stressful stimuli or situations trigger a series of neuroendocrine steps in the HPA axis; i.e., 
the release of corticotropin-releasing factor (CRF) from the hypothalamus, 
adrenocorticotropic hormone (ACTH) from the pituitary gland and finally glucocorticoids 
from the adrenal cortex. There is increasing evidence that this physiological response to 
stress is related to several aspects of drug addiction (Piazza & Le Moal, 1997; Sinha, 2001; 
Spealman et al., 2004). The work from Piazza and coworkers revealed that glucocorticoids 
were implicated in the DA response to cocaine and opioids (Marinelli et al., 1998; Marinelli 
et al., 1997; Piazza &Le Moal, 1997) and, therefore, the HPA axis was a possible target for 
addiction treatment. Glucocorticoid stress response seems to be essential for the acquisition, 
maintenance and reinstatement of stimulant self-administration (Goeders, 2002; Piazza et al., 
1991; Piazza and Le Moal, 1998).  
There are major and pervasive differences in the rodent and primate HPA system. First, the 
activation of the HPA in rodents relies predominantly on corticosterone, as opposed to 
cortisol in humans and NHP. There also seems to be discrepant age-related influences on 
hormones and cocaine. Rats display an increase in basal glucocorticoids as they age 
(Haugert et al., 1994; Meany et al., 1992), whereas no such difference was observed in NHP 
or humans (Goncharova & Lapin, 2002). More importantly, the distribution of corticotropin-
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releasing-factor (CRF) reactivity and that of corticoid receptors in the brain show great 
discrepancies in the amygdala (Bassett & Foote, 1992; Sanchez et al., 1999), hippocampus 
and pre-frontal cortex (PFC; Sanchez et al., 2000). The discrepancies in the amygdala and 
hippocampus are similar to the differences in the distribution of norepinephrine in those 
regions (Smith et al., 2006). These structures are important for learning and memory 
(McGaugh 2002; Tomaz et al., 1992) which, in turn, are also implicated in addictive 
behaviors (Garavan et al., 2000; Kilts et al., 2001; O’Brien et al., 1998). The amygdala also 
sends critical inputs to the striatum and PFC. 
The discrepancies in receptor distribution in the PFC are of particular interest. The PFC is 
another area relevant for cocaine effects. It is a critical structure in decision-making and is 
involved in stress responses (Weinberg et al., 2010). It has undergone a massive expansion in 
primates, with NHP sharing a high similarity with humans in terms of structure, 
neurochemistry and connections (Carmichael and Price, 1994, 1996; Hardman et al., 2002; 
Ongur et al., 2003; Porrino & Lyons, 2000). The predominance of glucocorticoid receptors in 
the primate PFC, compared to the hippocampus, suggests that in humans and NHP this 
structure plays an important role in the HPA negative feedback through GR-mediated 
mechanisms (Sanchez et al., 2000). Furthermore, increasing evidence has implicated PFC 
asymmetry with stimulant use and hormonal changes. Activity in the right PFC was 
positively correlated with elevated levels of cortisol and cocaine craving (Kalin et al., 1998; 
Volkow et al., 1999). Chronic use of cocaine was also correlated with greater volume loss of 
the right PFC (Liu et al., 1998).   
Despite these differences, cocaine-induced effects have shown a considerably similar 
response in rodents and primates. Plasma levels of ACTH, endorphin and corticosterone in 
rats increase in response to cocaine administration (Forman & Estilow, 1988; Levy et al., 
1991; Moldow & Fischman, 1987; Saphier et al., 1993) as also seen in NHP (Lima et al., 2008; 
Sarnyai et al., 1996). This same pattern is seen in humans, where ACTH and adrenaline 
levels were increased with cocaine infusions, along with its subjective effects such as 
euphoria (Mendelson et al., 2002). On the other hand, glucocorticoids show reinforcing 
properties of their own in rodents, whereas no such effect has been observed in primates 
(Broadbear et al., 1999). Broadbear and coworkers (2004) also reported that increases in 
ACTH and cortisol in NHP in response to cocaine infusion were in line with rodents studies, 
but the same did not hold true for opioid drugs, which induced an inhibition of HPA 
activity in monkeys.  
Although rodent and primate research presents direct mechanisms for the cocaine-induced 
activation of HPA axis, the impact that stress may have on the maintenance and relapse into 
drug seeking behavior is not so clear (Sinha, 2001). Initial studies with footshock paradigms 
in rodents have suggested that corticosterone may play a role in relapse (Deroche et al. 1997; 
Shaham et al. 1998; Mantsch and Goeders 1999). Rodent studies on reinstatement, however, 
yielded conflicting results (Erb et al., 1998; Goeders, 2003; Lu et al., 2001). Studies with 
squirrel monkeys by Spealman and coworkers suggest that the HPA axis is not involved in 
cocaine relapse (Lee et al., 2003). Rather, their following work indicated that the 
noradrenergic system is more likely to mediate stress response in cocaine reinstatement (Lee 
et al., 2004; but see Platt et al., 2007). Nevertheless, a recent study with rats suggests that 
cocaine reinstatement may be dependent on the interplay of both the HPA and 
noradrenergic systems (Graf et al., 2011). 
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4. Current and future strategies against cocaine addiction  
As mentioned above, an effective pharmacological treatment for cocaine addiction is still 
lacking. A recent study has attempted to implement a novel cocaine vaccine trial, with 
limited results (Martell et al., 2009), yet other trials are currently under way (Kinsey et al., 
2010). There are, nonetheless, several ongoing efforts to develop pharmacological strategies 
in primates to block or reduce the reinforcing properties of cocaine. From the findings 
discussed above, DA and 5-HT receptors and their respective transporters seem to currently 
be the most likely candidates for such an endeavor. In fact, the co-administration of DAT 
and SERT inhibitors has yielded encouraging results in primates (Howell, 2008), with such 
joint infusion leading to a better outcome, when compared to DAT alone. Strategies that 
influence CART transcription may also exert an important modulatory effect on stimulant-
seeking behavior and thus should not be overlooked in primate studies. On the other hand, 
NK1 and NK3 receptors seem to be more involved in the hyperlocomotor property of 
cocaine, even if the present lack of studies limits such a prediction, while the interaction of 
the stress response, via HPA axis, with the noradrenergic system seems promising in terms 
of preventing a relapse.  
The development of drugs with such mechanisms will require confirmation and further 
testing in NHP models. Well-established testing paradigms are just now being combined 
with neuroimaging techniques in monkeys, such as PET scans (Howell, 2008; Howell & 
Murnane, 2011) and fMRI (Jenkins et al., 2004; Brevard et al., 2006). Besides the several 
aspects already pointed out in this chapter, other advantages for using NHP (specifically 
related to imaging studies) are worth mentioning, including a similar cerebral metabolism 
and pharmacokinetics profile between humans and NHP, as opposed to rodents (Banks et 
al., 2007; Lyons et al., 1996; Porrino et al., 2002). Therefore, the translational value of NHP 
neuroimaging is unparallel to any other animal model.  
In summary, there is compelling evidence for the importance of NHP in cocaine research. In 
all neural pathways analyzed, the discrepancies detected between rodents and humans 
warrant some caution when generalizing the results observed in the former. Nevertheless, 
there are several lines of research related to cocaine that have few or no corresponding 
studies being held with primates. Besides the difficulty in handling and research costs, this 
may also be due to restrictions in the use of these animals for research, especially for large 
primates. The findings discussed in this chapter indicate that NHP will remain crucial for 
biomedical research for several years to come, as substitutes have not yet been made 
available. Therefore, the development of a clinically effective anti-cocaine or anti-relapse 
drug/vaccine will very likely depend on our ability to cope with the lack of studies and 
ever-mounting pressure against the use of animals in research.  
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